These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors. Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571 [TBL] [Abstract][Full Text] [Related]
27. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
28. Physicians make different decisions from nephrologists at serum creatinine 2.0 mg/dl. Tamba K; Kusano E; Tabei K; Kajii E; Asano Y Clin Exp Nephrol; 2009 Oct; 13(5):447-451. PubMed ID: 19387767 [TBL] [Abstract][Full Text] [Related]
29. Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study. Schmidt M; Mansfield KE; Bhaskaran K; Nitsch D; Sørensen HT; Smeeth L; Tomlinson LA BMJ; 2017 Mar; 356():j791. PubMed ID: 28279964 [No Abstract] [Full Text] [Related]
30. Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review. Lavergne A; Vigneau C; Polard E; Triquet L; Rioux-Leclercq N; Tattevin P; Golbin L Int J Antimicrob Agents; 2018 Sep; 52(3):344-349. PubMed ID: 29665445 [TBL] [Abstract][Full Text] [Related]
31. [Optimization of systolic heart failure treatment by general practitioners after hospital discharge: Are guidelines applied?]. Msadek S; De Lauzun I; Diarova J; Sauvion D; Gandolfini MP; Beloued J; Digne F; Krapf L Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):195-200. PubMed ID: 31253348 [TBL] [Abstract][Full Text] [Related]
35. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease. St Peter WL; Odum LE; Whaley-Connell AT Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme inhibitors in diabetics with hypertension--a cautionary note. Mohamed AS; Yaqoob M; Bell GM Nephron; 1990; 55(1):83-4. PubMed ID: 2352582 [No Abstract] [Full Text] [Related]
37. Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. Adhiyaman V; Asghar M; Oke A; White AD; Shah IU J R Soc Med; 2001 Oct; 94(10):512-4. PubMed ID: 11581344 [TBL] [Abstract][Full Text] [Related]
38. [Acute failure of transplanted kidney after administration of angiotensin converting enzyme inhibitors (iACE)]. Rell K; Serafinowicz A; Gaciong Z; Michnowska M; Lao M Pol Arch Med Wewn; 1993 May; 89(5):405-9. PubMed ID: 8367375 [TBL] [Abstract][Full Text] [Related]
39. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior. Chodoff P; Bischof RO; Nash DB; Laine C Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148 [TBL] [Abstract][Full Text] [Related]
40. Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit. Vijay A; Grover A; Coulson TG; Myles PS Anaesth Intensive Care; 2016 May; 44(3):346-52. PubMed ID: 27246933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]